Home » Topics » BioWorld Science

BioWorld Science
RSS

MicroRNA-31-5p levels defines disease course and clinical outcome in Crohn's disease

Oct. 30, 2018

New phase Ib/IIa study explores use of AG-019 for treatment of early-onset type 1 diabetes

Oct. 29, 2018

Innovate demonstrates preclinical proof of concept for larazotide in NASH mouse model

Oct. 29, 2018

Qrumpharma develops inhaled agent for nontuberculous mycobacterial infections

Oct. 29, 2018

New phase I trial evaluates TAK-981 in metastatic solid tumors or lymphomas

Oct. 29, 2018

Aduro initiates phase I study of ADU-1604 in metastatic melanoma

Oct. 29, 2018

Genentech presents data on faricimab and ranibizumab PDS in wet AMD

Oct. 29, 2018

Novartis reports year 2 data from brolucizumab phase III trials in wet AMD

Oct. 29, 2018

Phase II data presented for SEL-212 in symptomatic gout patients

Oct. 29, 2018

Novo Nordisk reports PIONEER 8 topline results with oral semaglutide in type 2 diabetes

Oct. 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...